Rating History for X4 Pharmaceuticals (XFOR) by Guggenheim
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/9/2026 | Michael Schmidt | New Coverage | Buy (N/A) |
12.00 (N/A) |
3.76 (4.22) |
12.23% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/9/2026 | Michael Schmidt | New Coverage | Buy (N/A) |
12.00 (N/A) |
3.76 (4.22) |
12.23% | Details |